LPIC
GILD icon

LeJeune Puetz Investment Counsel’s Gilead Sciences GILD Stock Holding History

LeJeune Puetz Investment Counsel’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		$2.82M Buy
34,035
+15
+0% +$1.24K 1.01% 27
2022
Q4 		$2.92M Buy
34,020
+1,050
+3% +$83.2K 1.09% 25
2022
Q3 		$2.03M Buy
32,970
+560
+2% +$35.3K 0.84% 35
2022
Q2 		$2M Buy
32,410
+4,115
+15% +$255K 0.78% 41
2022
Q1 		$1.68M Buy
28,295
+475
+2% +$30.4K 0.59% 60
2021
Q4 		$2.02M Buy
27,820
+80
+0.3% +$5.51K 0.68% 47
2021
Q3 		$1.94M Buy
27,740
+1,090
+4% +$76.6K 0.71% 45
2021
Q2 		$1.83M Sell
26,650
-75
-0.3% -$5.01K 0.68% 50
2021
Q1 		$1.73M Buy
26,725
+1,450
+6% +$93.5K 0.68% 48
2020
Q4 		$1.47M Buy
25,275
+1,025
+4% +$61.8K 0.64% 57
2020
Q3 		$1.53M Buy
24,250
+650
+3% +$45.1K 0.75% 48
2020
Q2 		$1.82M Sell
23,600
-3,500
-13% -$268K 0.95% 33
2020
Q1 		$2.03M Buy
27,100
+2,335
+9% +$161K 1.18% 24
2019
Q4 		$1.61M Sell
24,765
-1,620
-6% -$105K 0.75% 52
2019
Q3 		$1.67M Buy
26,385
+155
+0.6% +$10.1K 0.85% 45
2019
Q2 		$1.77M Buy
26,230
+1,400
+6% +$92.1K 0.92% 41
2019
Q1 		$1.61M Buy
24,830
+1,525
+7% +$101K 0.88% 45
2018
Q4 		$1.46M Buy
23,305
+2,565
+12% +$179K 0.91% 44
2018
Q3 		$1.6M Buy
20,740
+100
+0.5% +$7.55K 0.92% 41
2018
Q2 		$1.46M Buy
20,640
+175
+0.9% +$12.4K 0.9% 42
2018
Q1 		$1.54M Buy
20,465
+1,639
+9% +$130K 0.95% 35
2017
Q4 		$1.35M Buy
18,826
+691
+4% +$52.5K 0.83% 46
2017
Q3 		$1.47M Buy
18,135
+440
+2% +$33.6K 0.94% 38
2017
Q2 		$1.25M Buy
17,695
+1,120
+7% +$74.5K 0.85% 45
2017
Q1 		$1.13M Buy
16,575
+1,660
+11% +$117K 0.81% 46
2016
Q4 		$1.07M Buy
+14,915
New +$1.11M 0.82% 47

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

LeJeune Puetz Investment Counsel's GILD Position: Q1 2023 in Review

LeJeune Puetz Investment Counsel increased its Gilead Sciences (GILD) stake by 0.04% in Q1 2023, buying an estimated $1.24K and bringing the position to 34,035 shares worth $2.82M. The position accounts for 1.01% of the portfolio, ranked #27.

LeJeune Puetz Investment Counsel first reported a position in GILD in Q4 2016 and has held it in 26 quarters since. The position peaked at $2.92M in Q4 2022. 1,736 funds tracked by Wall St. Rank hold GILD as of Q1 2023.

  • LeJeune Puetz Investment Counsel held 34,035 shares of Gilead Sciences worth $2.82M as of Q1 2023.
  • LeJeune Puetz Investment Counsel bought 15 Gilead Sciences shares in Q1 2023, an estimated $1.24K.
  • Gilead Sciences made up 1.01% of LeJeune Puetz Investment Counsel's portfolio in Q1 2023, its #27 holding.
  • LeJeune Puetz Investment Counsel first reported a position in Gilead Sciences in Q4 2016 and has held it in 26 quarters since.
  • LeJeune Puetz Investment Counsel's Gilead Sciences position peaked at $2.92M in Q4 2022.
  • 1,736 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2023.

Based on LeJeune Puetz Investment Counsel's 13F filing for Q1 2023, filed 3 May 2023.